Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SUPRIYA LIFESCIENCE LTD.

NSE : SUPRIYABSE : 543434ISIN CODE : INE07RO01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE964.852.7 (+0.28 %)

PREV CLOSE ( ) 962.15

OPEN PRICE ( ) 964.20

BID PRICE (QTY) 964.85 (46)

OFFER PRICE (QTY) 966.85 (91)

VOLUME 20369

TODAY'S LOW / HIGH ( )960.50 996.90

52 WK LOW / HIGH ( )545.65 1085.5

NSE966.453.55 (+0.37 %)

PREV CLOSE( ) 962.90

OPEN PRICE ( ) 960.00

BID PRICE (QTY) 966.35 (1)

OFFER PRICE (QTY) 966.40 (27)

VOLUME 540297

TODAY'S LOW / HIGH( ) 959.90 997.40

52 WK LOW / HIGH ( )545.5 1085

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-03 2008

Management Info

Satish Waman Wagh - Chairman Saloni Satish Wagh - Managing Director

Registered Office

Address 207/208, Udyog Bhavan,Sonawala Road,Goregaon (East),
Mumbai,
Maharashtra-400063

Phone 022-40332727

Email supriya@supriyalifescience.com

Website www.supriyalifescience.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

22Apr Supriya Lifescience gets EIR for manuf
Supriya Lifescience has received the Establishment Inspection Report (EI..

22Apr Supriya Lifescience informs about upda
Supriya Lifescience has informed that the US Food and Drug Administratio..

17Feb Supriya Lifescience informs about tra
Further to its Letters dated February 04, 2026, February 09, 2026, and F..

17Dec Supriya Lifescience aims up to Rs 1,60
Supriya Lifescience is eyeing up to Rs 1,600 crore revenue from its Lote..

17Dec Supriya Lifescience moves higher on ai
Supriya Lifescience is currently trading at Rs. 737.00, up by 5.85 point..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	742.29	2091.2
Gross Profit	921.29	2747.79
Operating Profit	1010.95	3055.35
Net Sales	2765.28	8278.75

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kwality Pharma (BSE) 2498.25 (6.93%)	M.Cap ( in Cr)2592.23
Abbott India (BSE) 26250.00 (0.40%)	M.Cap ( in Cr)55811.29
Venus Remedies (BSE) 1682.35 (5.00%)	M.Cap ( in Cr)2248.80
Caplin Point Lab (BSE) 2331.00 (3.25%)	M.Cap ( in Cr)17748.73
Concord Biotech (BSE) 1344.85 (5.76%)	M.Cap ( in Cr)14069.31

Shareholding Pattern

	PROMOTERS	68.3%
	NON-INSTITUTION	20.84%
	FI/BANKS/INSURANCE	2.35%
	MUTUAL FUNDS/UTI	1.33%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Quantum Small Cap F...	2.73
ITI Large & Mid Cap...	1.70
ITI ELSS Tax Saver ...	1.49
ITI Pharma & Health...	1.39
WOC Pharma and Heal...	0.80
Motilal Oswal Nifty...	0.23
Motilal Oswal BSE H...	0.14

Risk Disclosures on Derivatives

Smart Quotes

SUPRIYA LIFESCIENCE LTD.